AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...

The global biopharma firm will build a new API production facility near its global headquarters in North Chicago.

Genmab reported strong Phase 3 trial results for epcoritamab in FL, secured FDA priority review, and raised its 2025 sales ...

AbbVie is investing $195 million to build a new north Chicago manufacturing plant to expand its active pharmaceutical ingredient production in the U.S. The investment is part of the biopharmaceutical ...

AbbVie announced a significant expansion at its North Chicago facility, with plans to enhance U.S. production capacities for ...

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint ...

AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.

In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...